EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

PI‐RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers

Angelo Orsini iD, Simone Ferretti, Annamaria Porreca, Pietro Castellan, Giulio Litterio, Davide Ciavarella, Antonio De Palma, Francesco Berardinelli, Andrea D Pizzi, Emanuela D'Angelo, Marta di Nicola, Luigi Schips und 1 weitere

The Prostate · 2025

DOI: 10.1002/pros.24832 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Prostate, 2025. Verfasst von Angelo Orsini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Urology Unit, Department of Medical, Oral and Biotechnological Sciences, 'G. d'Annunzio University', Chieti, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Academic Medical Centers, Multiparametric Magnetic Resonance Imaging, Prostate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The introduction of multiparametric prostate magnetic resonance imaging (mpMRI) has revolutionized prostate cancer (PCa) diagnosis, enhancing the localization of clinically significant prostate cancer (csPCa) and guiding targeted biopsies. However, significant disparities in the execution, interpretation, and reporting of prostate MRI examinations across centers necessitate greater standardization and accuracy. This study compares the diagnostic efficacy of mpMRI from academic and nonacademic centers in detecting csPCa and identifies factors associated with csPCa detection. Materials and Methods Between July 2018 and October 2023, we prospectively followed 810 men at SS. Annunziata Hospital of Chieti who underwent MRI/US fusion biopsies due to elevated prostate‐specific antigen (PSA) and/or abnormal digital rectal examination (DRE). Patients with mpMRI‐documented suspicious lesions classified as PI‐RADS ≥ 3 were included. Patients were divided into two groups based on the source of their mpMRI (academic or nonacademic centers). All biopsies were conducted using the MRI/US fusion technique. Clinical, mpMRI, and pathological data were collected and analyzed. Statistical analyses were performed using R software.

Results

The cohort included 354 patients from academic centers and 456 from nonacademic centers. There were no significant differences in patient demographics, such as age and PSA levels, between the groups. Patients at academic centers were more likely to receive a higher number of elevated PI‐RADS scores compared to those at nonacademic centers (PI‐RADS > 3: 72.6% vs. 62.3%, p = 0.003). Histopathological analysis revealed no significant differences in the ISUP grade distribution between groups. Increased age, PSA levels, and positive DRE were significantly associated with higher odds of detecting csPCa. Median PSA density was significantly higher in patients with csPCa compared to those without csPCa (0.14 vs. 0.11 ng/mL/cm³, p < 0.001). Academic centers exhibited a higher odds ratio for csPCa detection in patients with PI‐RADS scores > 3 compared to nonacademic centers.

Conclusion

Our study highlights significant variability in PI‐RADS score assignments between academic and nonacademic centers, affecting csPCa detection rates. This variability underscores the need for greater standardization in PI‐RADS scoring to reduce disparities and improve diagnostic uniformity across centers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAcademic Medical CentersMultiparametric Magnetic Resonance ImagingProstateHumansMaleMiddle AgedAgedProspective StudiesProstate-Specific AntigenImage-Guided Biopsy

Stichwörter der Autor:innen

PIRADSacademicclinically significant prostate cancercsPCampMRInonacademic

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Urology Unit, Department of Medical, Oral and Biotechnological Sciences, 'G. d'Annunzio University', Chieti, Italy.
  • Department of Medical Oral Science and Biotechnology, G. d'Annunzio University, Chieti, Italy.
  • Department of Urology, Universita degli Studi Gabriele d'Annunzio Chieti Pescara Dipartimento di Scienze Mediche Orali e Biotecnologiche, Chieti, Italy.
  • Department of Innovative Technologies in Medicine and Dentistry, G. D'Annunzio University, Chieti, Italy.
  • ITAB Institute for Advanced Biomedical Technologies, Gabriele d'Annunzio University of Chieti, Chieti, Italy.
  • Diagnostic Molecular Pathology, Unit of Anatomic Pathology, SS Annunziata Hospital, Chieti, Italy.

ORCID-Profile: Angelo Orsini, Michele Marchioni

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Orsini, A., Ferretti, S., Porreca, A., Castellan, P., Litterio, G., Ciavarella, D., De Palma, A., Berardinelli, F., Pizzi, A. D., D'Angelo, E., di Nicola, M., Schips, L., & Marchioni, M. (2025). PI‐RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers. The Prostate. https://doi.org/10.1002/pros.24832

Vancouver

Orsini A, Ferretti S, Porreca A, Castellan P, Litterio G, Ciavarella D, et al. PI‐RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers. The Prostate. 2025. doi:10.1002/pros.24832

BibTeX
@article{Orsini2025,
  author = {Orsini, Angelo and Ferretti, Simone and Porreca, Annamaria and Castellan, Pietro and Litterio, Giulio and Ciavarella, Davide and De Palma, Antonio and Berardinelli, Francesco and Pizzi, Andrea D and D'Angelo, Emanuela and di Nicola, Marta and Schips, Luigi and Marchioni, Michele},
  title = {PI‐RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers},
  journal = {The Prostate},
  year = {2025},
  doi = {10.1002/pros.24832}
}
Kostenlos starten →